Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Carl Icahn Increases His Ammunition against Jim Chanos in the Battle For Cheniere Energy

Page 1 of 2

In a recently submitted 13G filing with the SEC, legendary activist investor Carl Icahn‘s Icahn Capital LP revealed that it had increased its activist stake in the liquefied natural gas company Cheniere Energy, Inc. (NYSEMKT:LNG) by 17.2% to 22.68 million shares. The position amasses 9.59% of the company’s outstanding common stock and is valued at more than $1.23 billion at the current price.

Carl Icahn - Icahn Capital Lp

Mr. Icahn doesn’t need any introduction, being one of the most successful investors, who began his career as a stockbroker in 1961 and in 1978 started taking controlling stakes in individual companies. In the last almost 40 years, he has lead several companies and their management to change their course of action in order to increase shareholder value. As of June 30, Icahn Capital LP boasts a U.S. equity portfolio of $31.2 billion, with 70% invested nearly equally in stocks from the technology and industrial sectors. Although Icahn Capital held stakes in 24 companies at the end of June, top 10 of its holdings accounted for 91.54% of its equity portfolio.

Carl Icahn
Carl Icahn
Icahn Capital LP

Hedge funds and other big money managers like Icahn tend to have the largest amounts of their capital invested in large and mega-cap stocks, because these companies allow for a greater capital allocation. However, our backtests of hedge funds’ equity portfolios between 1999 and 2012 revealed that the 50 most popular stocks among hedge funds underperformed the market by seven basis points per month on average, showing that their most popular picks and the ones that received the bulk of their capital were not actually their best picks. On the other hand, their top small-cap ideas performed considerably better, beating the market by 95 basis points per month. This was confirmed in forward tests of our small-cap strategy since August 2012. The strategy, which involves imitating the 15 most popular small-cap picks among hedge funds has provided gains of 118%, beating the broader market by over 60 percentage points (see more details).

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!